Mediators of the inflammatory response to joint replacement devices

Nature Reviews Rheumatology

Volumn 7, Issue 10, 2011, Pages 600-608

  Cobelli, Neil ^a   Scharf, Brian ^b   Crisi, Giovanna M ^c   Hardin, John ^b   Santambrogio, Laura ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCERAMICS; ETANERCEPT; INFLAMMASOME; METAL; NALP3 INFLAMMASOME; POLYMER; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ARTHRALGIA; ASEPTIC OSTEOLYSIS; BONE DISEASE; CHRONIC INFLAMMATION; ENDOPROSTHESIS; ENZYME ACTIVATION; GOUT; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; JOINT MOBILITY; JOINT PROSTHESIS; MECHANICAL STRESS; MOLECULAR INTERACTION; OSTEOLYSIS; PARTICULATE MATTER; PRIORITY JOURNAL; PROSTHESIS FAILURE; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; WEAR DEBRIS;

CARRIER PROTEINS; FOREIGN-BODY REACTION; HUMANS; JOINT PROSTHESIS; OSTEOLYSIS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; TOLL-LIKE RECEPTORS;

EID: 80053925867     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.128     Document Type: Review

References (90)

1. Bozic, K. J. et al. The epidemiology of bearing surface usage in total hip arthroplasty in the United States. J. Bone Joint Surg. Am. 91, 1614-1620 (2009).
2. Canadian Institute for Health Information. Hip and Knee Replacements in Canada - Canadian Joint Replacement Registry (CJRR) 2008-2009 Annual Report [online] http://secure.cihi.ca/cihiweb/products/2008-cjrr-annual-report-en.pdf (2009).
3. Lee, K. & Goodman, S. B. Current state and future of joint replacements in the hip and knee. Expert Rev. Med. Devices 5, 383-393 (2008).
4. Buckwalter, A. et al. Results of Charnley total hip arthroplasty with use of improved femoral cementing techniques. a concise follow-up, at a minimum of twenty-five years, of a previous report. J. Bone Joint Surg. Am. 88, 1481-1485 (2006).
5. Sundfeldt, M., Carlsson, L. V., Johansson, C. B., Thomsen, P. & Gretzer, C. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop. 77, 177-97 (2006).
6. Goodman, S. B. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials 28, 5044-5048 (2007). (Pubitemid 47488481)
7. Harris, W. H. Wear and periprosthetic osteolysis: the problem. Clin. Orthop. Relat. Res. 393, 66-70 (2001).
8. Looney, R. J., Schwarz, E. M., Boyd, A. & O'Keefe, R. J. Periprosthetic osteolysis: an immunologist's update. Curr. Opin. Rheumatol. 18, 80-7 (2006). (Pubitemid 43740409)
9. Sargeant, A. & Goswami, T. Pathophysiological aspects of hip implants. J. Surg. Orthop. Adv. 15, 111-112 (2006).
10. Purdue, P. E., Koulouvaris, P., Potter, H. G., Nestor, B. J. & Sculco, T. P. The cellular and molecular biology of periprosthetic osteolysis. Clin. Orthop. Relat. Res. 454, 251-261 (2007). (Pubitemid 46074927)
11. Ito, S., Matsumoto, T., Enomoto, H. & Shindo, H. Histological analysis and biological effects of granulation tissue around loosened hip prostheses in the development of osteolysis. J. Orthop. Sci. 9, 478-487 (2004). (Pubitemid 39410177)
12. Stea, S. et al. Cytokines and osteolysis around total hip prostheses. Cytokine 12, 1575-1579 (2000).
13. O'Neill, L. A. Immunology. How frustration leads to inflammation. Science 320, 619-620 (2008). (Pubitemid 351928333)
14. Maitra, R. et al. Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis. Mol. Immunol. 47, 175-184 (2009).
15. Hirayama, T. et al. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles. J. Orthop. Res. 28, 984-992 (2011).
16. Maitra, R., Clement, C. C., Crisi, G. M., Cobelli, N. & Santambrogio, L. Immunogenecity of modified alkane polymers is mediated through TLR1/2 activation. PLoS ONE 3, e2438 (2008).
17. Islam, A. S., Beidelschies, M. A., Huml, A. & Greenfield, E. M. Titanium particles activate Toll-like receptor 4 independently of lipid rafts in RAW264.7 murine macrophages. J. Orthop. Res. 29, 211-217 (2011).
18. Piccinini, A. M. & Midwood, K. S. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 672395 (2010).
19. Tamaki, Y. et al. Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants. J. Rheumatol. 36, 598-608 (2009).
20. Holt, G., Murnaghan, C, Reilly, J. & Meek, R. M. The biology of aseptic osteolysis. Clin. Orthop. Relat. Res. 460, 240-252 (2007). (Pubitemid 47056504)
21. Charnley, J. Arthroplasty of the hip. A new operation. Lancet 1, 1129-1132 (1961).
22. Mäkelä, K. et al. Cemented versus cementless total hip replacements in patients fifty-five years of age or olderwith rheumatoid arthritis. J. Bone Joint Surg. Am. 93, 178-186 (2011).
23. Thomas, G. E. et al. The seven-year wear of highly cross-linked polyethylene in total hip arthroplasty: a double-blind, randomized controlled trial using radiostereometric analysis. J. Bone Joint Surg. Am. 93, 716-722 (2011).
24. Huo, M. H. & Brown, B. S. What's new in hip arthroplasty. J. Bone Joint Surg. Am. 85-A, 1852-1864 (2003). (Pubitemid 37129633)
25. Baudriller, H., Chabrand, P. & Moukoko, D. Modeling UHMWPE wear debris generation. J. Biomed. Mater. Res. B Appl. Biomater. 80, 479-485 (2007).
26. Ingham, E. & Fisher, J. The role of macrophages n osteolysis of total joint replacement. Biomaterials 26, 1271-1286 (2005). (Pubitemid 39314501)
27. Endo, M. et al. Comparison of wear, wear debris and functional biological activity of moderately crosslinked and non-crosslinked polyethylenes n hip prostheses. Proc. Inst. Mech. Eng. H 216, 111-122 (2002). (Pubitemid 34410659)
28. Atienza, C. Jr & Maloney, W. J. Highly cross-inked polyethylene bearing surfaces in total hip arthroplasty. J. Surg. Orthop. Adv. 17, 27-33 (2008).
29. Doorn, P. F. et al. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J. Biomed. Mater. Res. 42, 103-111 (1998). (Pubitemid 28413002)
30. Yoon, T. R., Rowe, S. M., Jung, S. T., Seon, K. J. & Maloney, W. J. Osteolysis in association with a total hip arthroplasty with ceramic bearing surfaces. J. Bone Joint Surg. Am. 80, 1459-1468 (1998). (Pubitemid 28503260)
31. Hatton, A. et al. Alumina-alumina artificial hip joints. Part I: a histological analysis and characterisation of wear debris by laser capture microdissection of tissues retrieved at revision. Biomaterials 23, 3429-3440 (2002). (Pubitemid 34615649)
32. Tipper, J. L. et al. Alumina-alumina artificial hip joints. Part II: characterisation of the wear debris from in vitro hip joint simulations. Biomaterials 23, 3441-3448 (2002). (Pubitemid 34615650)
33. Elfick, A., Green, S., Krikler, S. & Unsworth, A. The nature and dissemination of UHMWPE wear debris retrieved from periprosthetic tissue of THR. J. Biomed. Mater. Res. A 65, 95-108 (2003). (Pubitemid 37517290)
34. Schmalzried, T., Dorey, F. & McKellop, H. The multifactorial nature of polyethylene wear in vivo. J. Bone Joint Surg. Am. 80, 1234-1242 (1998).
35. Galvin, A. L. et al. Wear and biological activity of highly crosslinked polyethylene in the hip under low serum protein concentrations. Proc. Inst. Mech. Eng. H 221, 1-10 (2007). (Pubitemid 46443958)
36. Schmalzried, T., Peters, P., Maurer, B., Bragdon, C. & Harris, W. Long-duration metal-on-metal total hip arthroplasties with low wear of the articulating surfaces. J. Arthroplasty 11, 322-331 (1996). (Pubitemid 26123472)
37. Goldsmith, A. A., Dowson, D., Isaac, G. H. & Lancaster, J. G. A comparative joint simulator study of the wear of metal-on-metal and alternative material combinations in hip replacements. Proc. Inst. Mech. Eng. H 214, 39-47 (2000). (Pubitemid 32508300)
38. Dorlot, J., Christel, P. & Meunier, A. Wear analysis of retrieved alumina heads and sockets of hip prostheses. J. Biomed. Mater. Res. 23 (A3 Suppl.), 299-310 (1989). (Pubitemid 20043991)
39. Boehler, M. et al. Long-term results of uncemented alumina acetabular implants. J. Bone Joint Surg. Br. 76, 53-59 (1994). (Pubitemid 24029259)
40. Kuzyk, P. et al. Cross-linked versus conventional polyethylene for total hip replacement: a meta-analysis of randomised controlled trials. J. Bone Joint Surg. Br. 93, 593-600 (2011).
41. Urban, R. M. et al. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J. Bone Joint Surg. Am. 82, 457-476 (2000).
42. Delaunay, C., Petit, I., Learmonth, I. D., Oger, P. & Vendittoli, P. A. Metal-on-metal bearings total hip arthroplasty: the cobalt and chromium ions release concern. Orthop. Traumatol. Surg. Res. 96, 894-904 (2010).
43. Keegan, G. M., Learmonth, I. D. & Case, C. P. Orthopaedic metals and their potential toxicity in the arthroplasty patient: a review of current knowledge and future strategies. J. Bone Joint Surg. Br. 89, 567-573 (2007). (Pubitemid 46958760)
44. Malviya, A., Ramaskandhan, J., Holland, J. & Lingard, E. Metal-on-metal total hip arthroplasty. J. Bone Joint Surg. Am. 92, 1675-1683 (2010).
45. Charnley, J. Fracture of femoral prostheses in total hip replacement. A clinical study. Clin. Orthop. Relat. Res. 111, 105-120 (1975).
46. Harris, W. H., Schiller, A. L., Scholler, J. M., Freiberg, R. A. & Scott, R. Extensive localized bone resorption in the femur following total hip replacement. J. Bone Joint Surg. Am. 58, 612-618 (1976).
47. Ollivere, B., Darrah, C., Barker, T., Nolan, J. & Porteous, M. J. Early clinical failure of the Birmingham metal-on-metal hip resurfacing is associated with metallosis and soft-tissue necrosis. J. Bone Joint Surg. Br. 91, 1025-1030 (2009).
48. Kwon, Y. M. et al. Analysis of wear of retrieved metal-on-metal hip resurfacing implants revised due to pseudotumours. J. Bone Joint Surg. Br. 92, 356-361 (2010).
49. Pandit, H. et al. Pseudotumours associated with metal-on-metal hip resurfacings. J. Bone Joint Surg. Br. 90, 847-851 (2008). (Pubitemid 352009768)
50. Pandit, H. et al. Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties: evidence for a type IV immune response. Virchows Arch. 453, 529-534 (2008).
51. Davies, A. P., Willert, H. G., Campbell, P. A., Learmonth, I. D. & Case, C. P. An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J. Bone Joint Surg. Am. 87, 18-27 (2005). (Pubitemid 40094135)
52. Huber, M., Reinisch, G., Zenz, P., Zweymüller, K. & Lintner, F. Postmortem study of femoral osteolysis associated with metal-on-metal articulation in total hip replacement: an analysis of nine cases. J. Bone Joint Surg. Am. 92, 1720-1731 (2010).
53. Willert, H. G. et al. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J. Bone Joint Surg. Am. 87, 28-36 (2005).
54. Brach del Prever, E. M. et al. The biological reactivity of polyethylene wear debris is related with sterilisation methods of UHMWPE. Chir. Organi. Mov. 88, 291-304 (2003).
55. Bosetti, M., Zanardi, L., Bracco, P., Costa, L. & Cannas, M. In vitro evaluation of the inflammatory activity of ultra-high molecular weight polyethylene. Biomaterials 24, 1419-1426 (2003). (Pubitemid 36069108)
56. Renò, F., Bracco, P., Costa, L. & Cannas, M. Cytotoxicity and MMP-9 activation induced in human mononuclear cells by UHMWPE oxidation. Biomaterials 23, 3645-3650 (2002). (Pubitemid 34626568)
57. Smith, R. A., Maghsoodpour, A. & Hallab, N. J. In vivo response to cross-linked polyethylene and polycarbonate-urethane particles. J. Biomed. Mater. Res. A 93, 227-234 (2010).
58. Goodman, S. B. & Ma, T. Cellular chemotaxis induced by wear particles from joint replacements. Biomaterials 31, 5045-5050 (2010).
59. Lenz, R. et al. Response of human osteoblasts exposed to wear particles generated at the interface of total hip stems and bone cement. J. Biomed. Mater. Res. A 89, 370-378 (2009).
60. Kanaji, A. et al. Co-Cr-Mo alloy particles induce tumor necrosis factor alpha production in MLO-Y4 osteocytes: a role for osteocytes in particle-induced inflammation. Bone 45, 528-533 (2009).
61. Wang, C. T., Lin, Y. T., Chiang, B. L., Lee, S. S. & Hou, S. M. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials 31, 77-82 (2010).
62. Haynes, D. R. et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J. Bone Joint Surg. Br. 83, 902-911 (2001). (Pubitemid 32785565)
63. Teitelbaum, S. L. Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170, 427-435 (2007). (Pubitemid 47339379)
64. Wu, Y., Humphrey, M. B. & Nakamura, M. C. Osteoclasts - the innate immune cells of the bone. Autoimmunity 41, 183-194 (2008). (Pubitemid 351454988)
65. Boyce, B. F., Schwarz, E. M. & Xing, L. Osteoclast precursors: cytokine-stimulated mmunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol. 18, 427-432 (2006). (Pubitemid 44297290)
66. Kahn, A. J., Teitelbaum, S. L, Malone, J. D. & Krukowski, M. The relationship of monocytic cells to the differentiation and resorption of bone. Prog. Clin. Biol. Res. 110 Pt B, 239-248 (1982).
67. Alnaeeli, M. & Teng, YT Dendritic cells differentiate into osteoclasts in bone marrow microenvironment in vivo. Blood 113, 264-265 (2009).
68. Maitra, R. et al. Dendritic cell-mediated in vivo bone resorption. J. Immunol. 185, 1485-1491 (2010).
69. Lamkanfi, M. & Dixit, V. M. Inflammasomes: guardians of cytosolic sanctity. Immunol. Rev. 227, 95-105 (2009).
70. Caicedo, M. S. et al. Soluble and particulate Co-Cr-Mo alloy implant metals activate the nflammasome danger signaling pathway in human macrophages: a novel mechanism for mplant debris reactivity. J. Orthop. Res. 27, 847-854 (2009).
71. St Pierre, C. A. et al. Periprosthetic osteolysis: characterizing the innate immune response to titanium wear-particles. J. Orthop. Res. 28, 1418-1424 (2010).
72. Cassel, S. L. et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl Acad. Sci. USA 105, 9035-9040 (2008).
73. Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-647 (2008).
74. Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847-856 (2008).
75. Freeman, T. A., Parvizi, J., Della Valle, C. J. & Steinbeck, M. J. Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty. Fibrogenesis Tissue Repair 2, 5 (2009).
76. Hallab, N., Merritt, K. & Jacobs, J. J. Metal sensitivity in patients with orthopaedic mplants. J. Bone Joint Surg. Am. 83-A, 428-436 (2001). (Pubitemid 32221575)
77. Campbell, P. et al. in Histopathology of Metal-on-Metal Hip Joint Tissues (eds Rieker, C. et al.) 167-180 (World Tribology Forum in Arthroplasty, Gottingen, 2000).
78. Campbell, P. et al. The John Charnley Award: a study of implant failure in metal-on-metal surface arthroplasties. Clin. Orthop. Relat. Res. 453, 35-46 (2006). (Pubitemid 44900958)
79. Gamerdinger, K. et al. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cel receptor and major histocompatibility complex by nickel. J. Exp. Med. 197, 1345-1353 (2003). (Pubitemid 36617781)
80. Budinger, L. & Hertl, M. Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy 55, 108-115 (2000). (Pubitemid 30106015)
81. + T lymphocytes in the absence of professional antigen-presenting cells. J. Invest. Dermatol. 118, 172-179 (2002). (Pubitemid 34107439)
82. Thierse, H. J., Gamerdinger, K., Junkes, C., Guerreiro, N. & Weltzien, H. U. T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens. Toxicology 209, 101-107 (2005). (Pubitemid 40568635)
83. Chiu, R., Ma, T., Smith, R. L. & Goodman, S. B. Ultrahigh molecular weight polyethylene wear debris inhibits osteoprogenitor proliferation and differentiation in vitro. J. Biomed. Mater. Res. A 89, 242-247 (2009).
84. Nawrocki, B., Polette, M., Burlet, H., Birembaut, P. & Adnet, J. J. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene. J. Bone Miner. Res. 14, 288-294 (1999). (Pubitemid 29066255)
85. Takei, I. et al. Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints. J. Biomed. Mater. Res. 52, 613-620 (2000).
86. Nam, J. L. et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann. Rheum. Dis. 69, 976-986 (2010).
87. Rémy, A., Avouac, J., Gossec, L. & Combe, B. Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis. Clin. Exp. Rheumatol. 29, 96-103 (2011).
88. De Giglio, E. et al. Development and characterization of rhVEGF-loaded poly(HEMA-MOEP) coatings electrosynthesized on titanium to enhance bone mineralization and angiogenesis. Acta Biomater. 6, 282-290 (2010).
89. Zhang, Z. Y. et al. A comparison of bioreactors for culture of fetal mesenchymal stem cells for bone tissue engineering. Biomaterials 31, 8684-8695 (2010).
90. Hildebrandt, C., Büth, H. & Thielecke, H. A scaffold-free in vitro model for osteogenesis of human mesenchymal stem cells. Tissue Cell 43, 91-100 (2011).